Biosite Incorporated Product Pipeline Analysis

Publication Date	August 2008
Publisher	Global Markets Direct
Product Type	Report
Pages	44
ISBN Number	not applicable
Product Code	GMD04815

Price

£490.00
approximately: $749 | €546

PDF

Order above formats by FAX

Summary

This report is an insightful source for data, analysis and strategic insights into a Biosite Incorporated's pipeline and investigational products. The report also provides details on clinical trials covering trial phase, description, investigator information, primary and secondary end-points and trial results for products in development.

Scope

Details of development stage by sector and equipment type.
Pipeline products grouped by therapy area, development stage and trial phase.
Detailed information on clinical trials covering trial phase, description, investigator .nformation, primary and secondary end-points and trial results.
Trial updates, trial start and end dates, patient numbers and the trials primary outcome measures, secondary outcome measures.
Product updates covering estimated approval dates and estimated launch dates.
Descriptions of novel technologies relating to pipeline products of the company.
Patents and patent applications covered for the product.
News updates on key events relating to the product and its development.

Reasons to buy

A single source to fulfill competitor information relating to products in development.
Identify pipeline products that are potential competitor to your product lines.

Understand a company's strategic position by accessing detailed independent intelligence on its product pipeline.

Access clinical trial information to map trial results and plan targeted marketing activities.
Take corrective measures on your own development programs and R&D initiatives based on regulatory events of competitor product pipelines.
Identification of potential investment opportunities.
Build up knowledge base for potential distribution and marketing partners.
Helps avoid patent infringement.
Timelines from concept to market lets you keep track of market potential build for a new product.

Assess a company's future growth by determining its pipeline depth, for probable acquisition opportunities.

Content

1 List of Tables
- 1.2 List of Figures
2 Company Snapshot
- 2.1 Key Information
- 2.2 Company Overview
- 2.3 Financial Performance
- 2.4 Industry Outlook Cardiovascular Devices
- 2.5 Industry Outlook In Vitro Diagnostics
3 Business Description
- 3.1 Business Overview
- 3.2 Cardiovascular Products Product Line
  - 3.2.1 Overview
  - 3.2.2 Financials
  - 3.2.3 Market View
  - 3.2.4 Key Strategies
- 3.3 Other Products Product Line
  - 3.3.1 Overview
  - 3.3.2 Financials
  - 3.3.3 Market View
  - 3.3.4 Key Strategies
- 3.4 Major Products and Services
  - 3.4.1 Overview
4 History
5 business strategy
- 5.1 Mission Statement
- 5.2 Strategy
- 5.3 Corporate Social Responsibility
  - 5.3.1 Overview
6 value chain analysis
- 6.1 Manufacturing
  - 6.1.1 In House Manufacturing
  - 6.1.2 Outsourcing
- 6.2 Product Development
  - 6.2.1 Regulatory Approvals
  - 6.2.2 Clinical Trials
  - 6.2.3 Research and Development
- 6.3 Sales and Marketing
  - 6.3.1 Partnerships and Alliances
  - 6.3.2 Licensing Agreements
7 Competitors
8 Key Employees
9 Key Employee Biographies
10 Company Statement
11 Locations And Subsidiaries
- 11.1 Head Office
- 11.2 Other Locations & Subsidiaries
12 Recent Developments
- 12.1 Product News
  - 12.1.1 Jan 03, 2006: Biosite Announces U.S. 510(k) Filing for MPO Tests
  - 12.1.2 Aug 02, 2005: Biosite Announces Triage Stroke Panel Commercialization In Europe
13 Biosite Incorporated Pipeline Products
- 13.1 Biosite Incorporated Product Pipeline Analysis
  - 13.1.1 Biosite Incorporated Pipeline Products By Equipment Type
  - 13.1.2 Biosite Incorporated Pipeline Products By Development Stage
  - 13.1.3 Biosite Incorporated Pipeline Products By Therapy Area
  - 13.1.4 Biosite Incorporated Pipeline Products By Clinical Trials
  - 13.1.5 Biosite Incorporated Pipeline Products By News Summary
- 13.2 Triage Cardio Profiler Panel with MPO
  - 13.2.1 Product Description
  - 13.2.2 Product Status
  - 13.2.3 Clinical Trials
- 13.3 Triage NGAL Test
  - 13.3.1 Product Description
  - 13.3.2 Product Status
  - 13.3.3 Clinical Trials
- 13.4 Triage Stroke Panel
  - 13.4.1 Product Description
  - 13.4.2 Product Status
  - 13.4.3 Clinical Trials
  - 13.4.4 Product Milestone
- 13.5 Next Generation Triage CardioProfilER
  - 13.5.1 Product Description
  - 13.5.2 Product Status
- 13.6 Triage Sepsis Panel
  - 13.6.1 Product Description
  - 13.6.2 Product Status
  - 13.6.3 Clinical Trials
- 13.7 Triage MPO Test
  - 13.7.1 Product Description
  - 13.7.2 Product Status
  - 13.7.3 Clinical Trials
  - 13.7.4 Product Milestone
14 Appendix
- 14.1 Methodology
  - 14.1.1 Coverage
  - 14.1.2 Secondary Research
  - 14.1.3 Primary Research
  - 14.1.4 Expert Panel Validation
- 14.2 Contact Us
- 14.3 About Global Markets Direct
- 14.4 Disclaimer
1 List of Tables
- Table 1: Biosite Incorporated,Key Facts, 2006
- Table 2: Biosite Incorporated, Key Employees, 2006
- Table 3: Biosite Incorporated, Other Locations
- Table 4: Biosite Incorporated, Subsidiaries
- Table 5: Biosite Incorporated Pipeline Products by Equipment Type
- Table 6: Biosite Incorporated Pipeline Products By Development Stage
- Table 7: Biosite Incorporated Pipeline Products By Therapy Area
- Table 8: Biosite Incorporated Pipeline Products By Clinical Trials
- Table 9: Biosite Incorporated Pipeline Products By News Summaries
- 1.2 List of Figures
- Figure 1: Biosite Incorporated, Value Chain Analysis
- Figure 2: Biosite Incorporated Pipeline Products By Development Stage
- Figure 3: Global Markets Direct Methodology